Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02685722
Other study ID # CHIN-PLAGH-ST-008
Secondary ID
Status Completed
Phase Phase 1
First received January 21, 2016
Last updated February 18, 2016
Start date January 2012
Est. completion date December 2015

Study information

Verified date February 2016
Source Chinese PLA General Hospital
Contact n/a
Is FDA regulated No
Health authority China: Ethics Committee
Study type Interventional

Clinical Trial Summary

This study for a six-month trials, Randomized, open, and parallel comparison before and after its own, Stage test includes screening stage, treatment period and follow-up period. In accordance with chronic wound criteria for the patient, By producing the principle of random number, Were randomly divided into UC-MSCs Gel group or Gel group, The researchers according to the situation of wound healing time and decided to use the secondary treatment, To observe the clinical efficacy and safety.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 17 Years to 78 Years
Eligibility Inclusion Criteria:

- Older than 17 year old male or female (pregnancy);

- Has the ability to care for, has the ability to self signed informed consent, 7 to 17 years of age must be signed by the guardian informed consent;

- The process of psychological stability, can finish the tes

Exclusion Criteria:

- Allergic constitution, or known allergic to pork or beef source products, gao min physique person;

- The wound is more than 10 cm by 10 cm;

- People with mental illness, drug abusers and or other items;

- 1 month used or are using the sugar metabolism of drugs, such as corticosteroids, thiazide diuretics, tricyclic antidepressants, etc;

- 3 month participated in other similar test;

- Serious infectious disease not controller;

- With surgery, such as severe trauma stress situation;

- Always had a history of tumor;

- Clinical researchers or for other reasons can't cooperate with the doctors, and other information is not suitable for clinical study of patients.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Biological:
UC-MSCs Gel group
This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.By generating a random number of principle,Observation of UC-MSCs Gel group patients efficacy, safety and tolerability of selective parameter.
Other:
Gel group
This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.By generating a random number of principle,observed and compared Gel group patients may be no efficacy.

Locations

Country Name City State
China Chinese PLA General Hospital Beijing

Sponsors (1)

Lead Sponsor Collaborator
Chinese PLA General Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of Adverse Events Frequency and severity of Adverse Events 6 months Yes
Secondary Relative Wound Area Regression of 40% or More at 6 Week 6 week Yes